• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Abbott CEO touts future of biowearables in first-ever healthcare company keynote at CES

Abbott CEO touts future of biowearables in first-ever healthcare company keynote at CES

January 6, 2022 By Sean Whooley

Abbott monitor CES Lingo
Eliud Kipchoge is training with Abbott’s Libre Sense to monitor his glucose levels to help him achieve optimal athletic performance. [Image courtesy of Abbott]
Abbott (NYSE:ABT) Chair & CEO Robert B. Ford highlighted what the future holds as he presented the first healthcare keynote ever at CES.

Speaking at the Consumer Electronics Show (CES) 2022 event, Ford headlined the “Human-Powered Health: Unlocking the Possibility of You” event, announcing that Abbott is developing a new category of biowearables for athletes called “Lingo.”

“Technology gives us the power to digitize, decentralize and democratize healthcare, create a shared language between you and your doctor – and put more control of your health in your hands,” Ford said. “We’re creating a future that will bring you and your loved ones care that’s more personal and precise. It’s happening right now. And its potential is no less than incredible.”

Find out about more digital health technologies promoted at this year’s CES. 

Abbott Park, Illinois–based Abbott is designing Lingo biowearables to translate the body’s language into actionable data, helping to track and measure general health and wellness. For example, sensor technology comprising Lingo will track key signals in the body like glucose, ketones and lactate, and could even someday track alcohol levels, Abbott said.

The Lingo platform will extend the sensing platform Abbott created for aiding people with diabetes — the FreeStyle Libre continuous glucose monitor with a small sensor worn on the back of the arm. As part of the CES event, actress and comedian Sherri Shepherd shared her experience with Freestyle Libre 2 to emphasize the impact of the sensor technology.

Abbott has since enhanced the platform with design for athletes, having launched the Libre Sense Glucose Sport Biowearable in Europe, with famed marathoner Eliud Kipchoge using the biowearable to optimize their fueling ahead of training. Abbott said Lingo aims to expand glucose monitoring to the management of weight, sleep, energy and thoughts.

The company is developing a ketone biowearable to aid in dieting and weight loss, along with a lactate biowearable to track continuous lactate build-up during exercise, which can indicate athletic performance.

“This will be like having a window into your body,” Ford said. “It’s science that you will be able to access any time so you can understand what your body is telling you and what it needs. Our vision is that Lingo will go far beyond today’s wearables for consumers to help you proactively manage your health, nutrition and athletic performance.”

Filed Under: Business/Financial News, Diabetes, Digital Health, Featured, News Well, Patient Monitoring, Weight loss Tagged With: Abbott, Biowearables, CES, CES 2022, wearable, wearable sensors

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy